Arch Point Investors Sarepta Therapeutics, Inc. Transaction History

Arch Point Investors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$76.53 - $135.58 $382,650 - $677,900	-5,000 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$72.81 - $156.91 $1.4 Million - $3.02 Million	-19,234 Reduced 79.37%	5,000 $377,000
Q2 2019 Jul 26, 2019	BUY	$112.21 - $151.95 $280,525 - $379,875	2,500 Added 11.5%	24,234 $3.68 Million
Q1 2019 May 10, 2019	BUY	$106.67 - $151.68 $2.32 Million - $3.3 Million	21,734 New	21,734 $2.59 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $95,280 - $113,500	-2,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $71,460 - $94,300	2,000	2,000 $91,000

535

89.8M

1.66M

1.44M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.45B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.